HLNCF:OTCMKTS
Haleon PLC
US$ 4,89
arrow_upward
+0,85%(+0,041) 1D
15 de out., 16:00:00 GMT-4 · USD
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para HLNCF…
Abrir
US$ 4,95
Alta
US$ 4,95
Baixa
US$ 4,89
Valor de mercado
43,44 bi
Volume médio
9,92 mil
Volume
4,56 mil
Alto — 52 sem
US$ 5,75
Baixo — 52 sem
US$ 4,15
Beta
-21,47
Ações em circulação
8,80 bi
Nº de funcionários
25 mil
Abrir
US$ 4,95
Alta
US$ 4,95
Baixa
US$ 4,89
Valor de mercado
43,44 bi
Volume médio
9,92 mil
Volume
4,56 mil
Alto — 52 sem
US$ 5,75
Baixo — 52 sem
US$ 4,15
Beta
-21,47
Ações em circulação
8,80 bi
Nº de funcionários
25 mil
Notícias
De fontes da web e parceiros de notícias
ad-hoc-news.de
·
há 16 horas
UBS trims Haleon growth forecast to 3.1 percent for Haleon stock
Yahoo Finance
·
há 1 dia
Is Haleon (LSE:HLN) Using Excedrin’s Nostalgic Game To Redefine Consumer Health Brand Moats?
Simply Wall Street
·
há 1 dia
Haleon (LSE:HLN) Stock May Be 43% Undervalued On Cash Flow
Yahoo Finance
·
há 1 dia
Is Haleon (LSE:HLN) Undervalued After A 11% Three Year Return?
Perfil
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
Sobre Haleon PLC